Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Psychol Health. 2022 Mar 3;38(12):1649–1664. doi: 10.1080/08870446.2022.2040500

Table 1.

Demographic and clinical characteristics of the study sample.

Variable Frequency (n) Percent (%)
Total 65 100
Sex
Male 21 31.3
Female 41 61.2
* 5 7.5
Race/Ethnicity
Non-Hispanic White 39 58.2
Black/African American 10 14.9
Hispanic or Latino 1 1.5
Asian/Asian American 1 1.5
Other 1 1.5
* 15 22.4
Annual Household Income
≥ $15,000 – 39,999 36 53.7
$40,000 – 79,999 15 22.4
$80,000 – 149,999 7 10.5
$150,000 – 249,999 1 1.5
* 8 11.9
Disease Stage at Diagnosis
I 15 22.4
II 8 11.9
III 28 41.8
IV 16 23.9
Early (I, II) 23 34.3
Late (III, IV) 44 65.7
Chemotherapy at study entry
Yes 21 31.3
No 38 56.7
* 8 11.9
Radiation at study entry
Yes 3 4.5
No 57 85.1
* 7 10.4
Chemotherapy ever
Yes 48 71.6
No 12 17.9
* 7 10.4
Radiation ever
Yes 38 56.7
No 22 32.8
* 7 10.4

Note.

*

denotes missing data